QIAGEN N.V. cotiza a 45.56 USD y tiene una capitalización bursátil de $9.4B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and vira…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.62 | $0.54 | $0.62 |
| Estimado | $0.62 | $0.60 | $0.54 | $0.62 |
| Sorpresa | — | +3.3% | +0.0% | +0.0% |
| Métrica | QGEN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 62.2% | 57.0% | +5.1% |
| Operating Margin | 22.3% | -38.6% | +60.9% |
| Net Margin | 20.3% | -33.6% | +53.9% |
| FCF Margin | 21.7% | -13.9% | +35.5% |
| ROE | 11.3% | -40.4% | +51.6% |
| ROA | 6.8% | -32.0% | +38.8% |
| Current Ratio | 3.90 | 2.84 | +1.06 |
| Debt / Equity | 0.44 | 0.28 | +0.16 |